—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Ascendis Pharma AS (ASND) — Quality & forensics

As of 2026-11-03 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.

The Closelooknet module scores

53 /100 composite · 7 modules · general weight set

Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.

Financial forensics — the academic screens

4.11 Altman Z-Score

Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.

5/9 Piotroski F-Score

Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.

-3.07 Beneish M-Score

Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.

Continue: the ASND chart & overview · the earnings record

FAQ · from the current data · as of 2026-11-03

Quick answers

What is Ascendis Pharma AS's Closelooknet quality reading?

The composite reads 53/100 across 7 modules, as of 2026-11-03: valuation 25, quality 63, growth 76, balance sheet 33, cash quality 79, capital allocation 19, momentum 67. Closelooknet scores are research diary readings, not ratings or investment advice.

What is Ascendis Pharma AS's Altman Z-Score?

4.11, which sits in the safe zone (above 2.99) as of 2026-11-03. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.

What is Ascendis Pharma AS's Piotroski F-Score?

5 of 9, as of 2026-11-03. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.

What does Ascendis Pharma AS's Beneish M-Score indicate?

-3.07 — below the −1.78 manipulation-risk threshold, as of 2026-11-03. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.